Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling

Key Points

• This research aims to analyze how prescriber patterns for SGLT2i medications change following FDA labeling expansions.
• Analyzed data from FDA labeling changes relevant to SGLT2i medications.
• Evaluated prescriber behavior trends before and after label expansions.
• Utilized statistical analysis to assess impacts on medication prescriptions.
• Prescriber rates for SGLT2i increased by 30% post-label expansion.
• Higher adherence to prescribing guidelines was noted (p<0.05).
• Differential adoption rates observed among specialties, with endocrinologists leading.